Clinical Trial Update: Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the optimal treatment plan for hypertensive patients with anti-AT1 receptor autoantibodies. The current status is not provided in the d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Hypertension | Phase 4 | Status: UNKNOWN